TRENDS
BY SAHELY MUKERJI | SEPTEMBER 2024
Between 2024 and 2034, ASC volume will go up 21 percent to 44 million, according to Sg2’s 2024 Impact of Change report.
Read More >
BY SAHELY MUKERJI | AUGUST 2023
ASCs will see 12 percent and 22 percent growth in the next 5 and 10 years, respectively, according to Sg2’s 2023 Impact of Change Forecast Highlights.
Read More >
BY ALEX TAIRA | MAY 2023
Thanks to advancements in medical techniques and devices, surgeons are performing an increasing number of total joint surgeries in the outpatient setting.
Read More >
BY SAHELY MUKERJI | AUGUST 2022
ASCs will see 15 percent and 25 percent growth in the next 5 and 10 years, respectively, according to Sg2’s 2022 Impact of Change Forecast Highlights.
Read More >
BY BRIANNA MOTLEY AND TONY GUTH | JANUARY 2022
ASCs are proliferating nationwide. At the ground level, however, markets vary substantially in their pace of procedural shift into ASCs, leaving legacy health systems’ share and revenue vulnerable to varying degrees.
Read More >
BY CHRIS BISHOP AND CHRISTOPHER NANSON, MD | JANUARY 2022
Total joint replacement (TJR) surgeries have been steadily migrating from inpatient to outpatient settings in recent years, and that trend is building momentum even faster than previously anticipated. We believe that at least 70 percent of TJR surgery volume, perhaps more, can now be outpatient.
Read More >
BY TAYLOR BURNS | FEBRUARY 2021
Prior to the ongoing coronavirus pandemic, the national ASC market was already experiencing substantial growth due to its placement across two converging trends: the consumerization of healthcare services and the ongoing industry-wide transition from fee-for-service care to value-based care.
Read More >
BY DANIEL I. LEVIN | OCTOBER 2020
HealthCare Appraisers released its 2020 ASC Valuation and Benchmarking Survey in spring. ASCA collaborated with HealthCare Appraisers on conducting the survey, which includes insights from owners and managers of more than 1,200 ASCs throughout the US.
Read More >